ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $271,000 | +45.7% | 132,385 | +104.9% | 0.00% | – |
Q4 2021 | $186,000 | -32.1% | 64,623 | 0.0% | 0.00% | – |
Q3 2021 | $274,000 | -2.8% | 64,623 | +21.2% | 0.00% | – |
Q2 2021 | $282,000 | +10.6% | 53,312 | -2.8% | 0.00% | – |
Q1 2021 | $255,000 | +40.9% | 54,866 | 0.0% | 0.00% | – |
Q4 2020 | $181,000 | -0.5% | 54,866 | 0.0% | 0.00% | – |
Q3 2020 | $182,000 | -1.6% | 54,866 | 0.0% | 0.00% | – |
Q2 2020 | $185,000 | -23.9% | 54,866 | -13.4% | 0.00% | – |
Q1 2020 | $243,000 | -26.6% | 63,328 | +15.4% | 0.00% | – |
Q4 2019 | $331,000 | -21.7% | 54,866 | -1.9% | 0.00% | – |
Q3 2019 | $423,000 | -44.2% | 55,943 | 0.0% | 0.00% | – |
Q2 2019 | $758,000 | +150.2% | 55,943 | 0.0% | 0.00% | – |
Q1 2019 | $303,000 | +82.5% | 55,943 | 0.0% | 0.00% | – |
Q4 2018 | $166,000 | -67.5% | 55,943 | -10.7% | 0.00% | – |
Q3 2018 | $511,000 | -16.2% | 62,670 | 0.0% | 0.00% | – |
Q2 2018 | $610,000 | +24.2% | 62,670 | +11.0% | 0.00% | – |
Q1 2018 | $491,000 | -30.6% | 56,475 | 0.0% | 0.00% | – |
Q4 2017 | $707,000 | – | 56,475 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
CSS LLC/IL | 476,831 | $607,960 | 0.04% |
Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
King Wealth Management Group | 16,000 | $20 | 0.00% |